drugset / Trial / NCT04803305
Study to Compare the Effects of Repeated Doses of an Investigational New Drug and a Placebo on Appetite in Advanced Cancer and Anorexia
RandomizedSequentialTriple-blindTreatment
Summary
Study to compare the effects of the investigational new drug (PF-06946860) and a placebo on appetite and to find out how participants with advanced cancer and anorexia feel after receiving repeated subcutaneous (SC-injected under the skin) doses.
Timeline
- Start
- 2021-05-11
- Primary completion
- 2022-04-14
- Completion
- 2022-08-09
Outcome
Missed primary endpoint
registry analysis (superiority test); Placebo vs PF-06946860 200mg Q3W; Mean Difference (Final Values) -0.60 (90% CI -2.38 to 1.18) NCT04803305 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ponsegromab | Monoclonal antibody | — | Subcutaneous |